HansBiomed Corporation (KOSDAQ:042520)
South Korea flag South Korea · Delayed Price · Currency is KRW
22,300
-750 (-3.25%)
At close: Jul 6, 2026

HansBiomed Revenue

HansBiomed had revenue of 34.49B KRW in the quarter ending March 31, 2026, with 42.77% growth. This brings the company's revenue in the last twelve months to 110.50B, up 30.99% year-over-year. In the fiscal year ending September 30, 2025, HansBiomed had annual revenue of 89.78B with 10.65% growth.

Revenue (ttm)
110.50B
Revenue Growth
+30.99%
P/S Ratio
3.30
Revenue / Employee
369.57M
Employees
299
Market Cap
364.38B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 202589.78B8.64B10.65%
Sep 30, 202481.14B3.11B3.98%
Sep 30, 202378.03B3.57B4.80%
Sep 30, 202274.46B15.36B25.99%
Sep 30, 202159.10B-21.00B-26.22%
Sep 30, 2020 Pro Pro Pro
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
NIBEC32.34B
S.Biomedics16.48B
Kangstem Biotech3.42B
Inventage Lab3.16B
Y-Biologics2.79B
IntoCell2.47B
curacle co.,ltd.1.06B
Ensol Biosciences537.46M
Revenue Rankings